Shay Capital’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Shay Capital’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-50,000	Closed	-$181K	–	532
2022 Q4	$181K	Buy	+50,000	New	+$327K	0.06%	201

Other funds holding LUMO

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JFG

Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LPC

Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Shay Capital's LUMO Position: Q1 2023 in Review

Shay Capital sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q1 2023, closing a stake of 50,000 shares — an estimated $181K sold.

Shay Capital first reported a position in LUMO in Q4 2022 and held it in 1 quarter. The position peaked at $181K in Q4 2022. 36 funds tracked by Wall St. Rank hold LUMO as of Q1 2023.

Shay Capital reported no remaining Lumos Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Shay Capital sold 50,000 Lumos Pharma, Inc. Common Stock shares in Q1 2023, an estimated $181K.
Shay Capital first reported a position in Lumos Pharma, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
Shay Capital's Lumos Pharma, Inc. Common Stock position peaked at $181K in Q4 2022.
36 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q1 2023.

Based on Shay Capital's 13F filing for Q1 2023, filed 15 May 2023.